Physician

Morgan Lawrence Magid, MD

According to 2025 Medicare claims, Morgan Magid, MD (NPI: 1417958273) practices dermatology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY - PACIFIC, P.C. (NPI: 1770361875; TIN: 770440158) and primary practice location at 95065-1709.

Magid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,416 traditional Medicare patients, billed 19,522 HCPCS/CPT codes, and received $1,295,255 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,221 prescription claims across 828 beneficiaries totaling $1,479,942 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 2 records totaling $40. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $156,978 to $1,479,942. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,913	17,218	$1,014,857
2016	1,980	17,481	$1,002,951
2017	2,155	18,851	$1,137,202
2018	2,214	19,448	$1,134,176
2019	2,316	21,865	$1,343,123
2020	2,017	16,913	$1,089,639
2021	2,142	18,882	$1,316,088
2022	2,323	20,667	$1,370,960
2023	2,367	20,561	$1,353,398
2024	2,416	19,522	$1,295,255

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	556	1,413	$156,978
2016	615	1,588	$161,198
2017	680	1,725	$166,796
2018	745	1,922	$168,373
2019	762	2,092	$305,154
2020	717	2,022	$474,883
2021	773	2,109	$620,271
2022	794	2,190	$612,638
2023	835	2,212	$1,007,559
2024	828	2,221	$1,479,942

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	696	842	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,748	2,976	$69
17000	Destruction of precancer skin growth, 1 growth	1,035	1,371	$43
88305	Pathology examination of tissue using a microscope, intermediate complexity	1,017	2,141	$31
17003	Destruction of precancer skin growth, 2-14 growths	859	6,366	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	46	3,668	$960,011
Humira Pen	Adalimumab	16	448	$190,903
Dupixent Pen	Dupilumab	15	406	$57,220
Betamethasone Dipropionate	Betamethasone Dipropionate	319	9,359	$13,495
Calcipotriene	Calcipotriene	49	1,556	$6,937

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$40	Galderma Laboratories, L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Morgan Lawrence Magid, MD?

Tedicare shows public-source Medicare data for Morgan Lawrence Magid, MD (NPI 1417958273), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Morgan Lawrence Magid, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Morgan Lawrence Magid, MD?

Morgan Lawrence Magid, MD is linked to FOREFRONT DERMATOLOGY - PACIFIC, P.C. (billing NPI 1770361875) in the available physician profile data.

Does Morgan Lawrence Magid, MD have Open Payments data?

Morgan Lawrence Magid, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.